Combined with the previous results, it was shown that inhibiting NEK2 could promote the expression of HMOX1 through Keap1/Nrf2, enhance the ferroptosis sensitivity of gastric cancer cells, and further affect the cell biological function. This evidence concerns the gene HMOX1 and gastric cancer.